Kapitalo Investimentos’s Biogen BIIB Stock Holding History

Kapitalo Investimentos’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,472	Closed	-$225K	–	108
2024 Q4	$225K	Buy	1,472 +299	+25%	+$50.4K	0.15%	78
2024 Q3	$227K	Buy	+1,173	New	+$245K	0.06%	137
2023 Q4	–	Sell	-2,379	Closed	-$611K	–	548
2023 Q3	$611K	Buy	2,379 +698	+42%	+$187K	0.08%	83
2023 Q2	$479K	Buy	1,681 +1,206	+254%	+$359K	0.09%	101
2023 Q1	$132K	Buy	475 +375	+375%	+$104K	0.04%	257
2022 Q4	$27.7K	Buy	+100	New	+$28.2K	0.02%	175

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kapitalo Investimentos's BIIB Position: Q1 2025 in Review

Kapitalo Investimentos sold out of Biogen (BIIB) in Q1 2025, closing a stake of 1,472 shares — an estimated $225K sold.

Kapitalo Investimentos first reported a position in BIIB in Q4 2022 and held it in 6 quarters. The position peaked at $611K in Q3 2023. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

Kapitalo Investimentos reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
Kapitalo Investimentos sold 1,472 Biogen shares in Q1 2025, an estimated $225K.
Kapitalo Investimentos first reported a position in Biogen in Q4 2022 and held it in 6 quarters.
Kapitalo Investimentos's Biogen position peaked at $611K in Q3 2023.
883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Kapitalo Investimentos's 13F filing for Q1 2025, filed 7 May 2025.